Dr. Dvorak is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA 02215Phone+1 617-667-4343
Education & Training
Massachusetts General HospitalResidency, Pathology-Anatomic and Clinical, 1963 - 1965
Harvard Medical SchoolClass of 1963
Certifications & Licensure
MA State Medical License 1964 - 2017
American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 17 citationsReconciling VEGF With VPF: The Importance of Increased Vascular Permeability for Stroma Formation in Tumors, Healing Wounds, and Chronic InflammationHarold F. Dvorak
Frontiers in Cell and Developmental Biology. 2021-03-23 - 51 citationsTumors: Wounds That Do Not Heal-A Historical Perspective with a Focus on the Fundamental Roles of Increased Vascular Permeability and Clotting.Harold F. Dvorak
Seminars in Thrombosis and Hemostasis. 2019-05-16 - 16 citationsEarly Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.Basel Sitohy, Sung-Hee Chang, Tracey E. Sciuto, Elizabeth M. Masse, Mei Shen
The American Journal of Pathology. 2017-10-01
Lectures
- 28th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and MetastastasisHarvard Medical School, Cambridge, Massachusetts - 9/30/2013
- 28th Annual Critical Issues in Tumor Microenvironment, Angiogenesis and MetastastasisHarvard Medical School, Cambridge, Massachusetts - 9/30/2013
Press Mentions
7 Big Questions About Cancer, AnsweredJanuary 29th, 2025
2020 Szent-Györgyi Prize Awarded to a Pioneering Researcher Who Has Unlocked Workings of Cancer Drugs of Natural Product OriginFebruary 13th, 2020
New Drug Candidate Is Promising Therapeutic Option for Angiogenic Retinal DiseasesOctober 14th, 2015
Grant Support
- Molecular Dissection Of The Angiogenic Response Induced By VEGF-ANational Cancer Institute2009–2012
- Administrative CoreNational Cancer Institute2009–2012
- Spatial And Temporal Regulation Of AngiogenesisNational Cancer Institute2002–2012
- Vegfs In Tumor Lymphatic MetastasisNational Cancer Institute2009–2011
- Training Program In Angiogenesis &InflammationNational Heart, Lung, And Blood Institute2003–2011
- Adenoviral Vectors For Delivery Of Angiogenic CytokinesNational Heart, Lung, And Blood Institute2001–2008
- Permselective Properties Of Tumor And Wound Blood VesselNational Cancer Institute1989–2004
- Structure And Function Of New Blood VesselsNational Cancer Institute2002
- Training Program In Angiogenesis And InflammationNational Heart, Lung, And Blood Institute1998–2002
- VPF/VEGF In Breast Cancer AngiogenesisNational Heart, Lung, And Blood Institute1995–1998
- Gordon Research--Angiogenesis And MicrocirculationNational Heart, Lung, And Blood Institute1997
- Pathogenesis Of Tumor Stroma Generation &Wound HealingNational Cancer Institute1993–1997
- Biology Of Solid &Ascites Tumor GrowthNational Cancer Institute1988–1992
- Biology Of Solid Tumor Growth And Immune RejectionNational Cancer Institute1985–1989
- Pathogenesis Of Tumor Stroma GenerationNational Cancer Institute1985–1987
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
